{"id": "train_1_9", "text": "In case-control samples, two SNPs (rs1937970 and @GENE$) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for @DISEASE$ (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_entity_marker": "In case-control samples, two SNPs (rs1937970 and [E1]@GENE$[/E1]) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for [E2]@DISEASE$[/E2] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_typed_entity_marker": "In case-control samples, two SNPs (rs1937970 and [GENE]@GENE$[/GENE]) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for [DISEASE]@DISEASE$[/DISEASE] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [49, 55], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_idx_in_text_with_typed_entity_marker": [55, 61], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_195", "text": "In @DISEASE$ patients, TLR-induced @GENE$ secretion was impaired by both NOD2-dependent and -independent mechanisms.", "text_with_entity_marker": "In [E1]@DISEASE$[/E1] patients, TLR-induced [E2]@GENE$[/E2] secretion was impaired by both NOD2-dependent and -independent mechanisms.", "text_with_typed_entity_marker": "In [DISEASE]@DISEASE$[/DISEASE] patients, TLR-induced [GENE]@GENE$[/GENE] secretion was impaired by both NOD2-dependent and -independent mechanisms.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [3, 12], "entity_1_idx_in_text_with_entity_marker": [7, 16], "entity_1_idx_in_text_with_typed_entity_marker": [12, 21], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [35, 41], "entity_2_idx_in_text_with_entity_marker": [48, 54], "entity_2_idx_in_text_with_typed_entity_marker": [60, 66], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_1_44", "text": "@DISEASE$ is associated with decreased expression of mucosal @GENE$.", "text_with_entity_marker": "[E1]@DISEASE$[/E1] is associated with decreased expression of mucosal [E2]@GENE$[/E2].", "text_with_typed_entity_marker": "[DISEASE]@DISEASE$[/DISEASE] is associated with decreased expression of mucosal [GENE]@GENE$[/GENE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [0, 9], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_idx_in_text_with_typed_entity_marker": [9, 18], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [61, 67], "entity_2_idx_in_text_with_entity_marker": [74, 80], "entity_2_idx_in_text_with_typed_entity_marker": [86, 92], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_1_248", "text": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and @GENE$, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.", "text_with_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and [E1]@GENE$[/E1], in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and [GENE]@GENE$[/GENE], in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [73, 79], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_idx_in_text_with_typed_entity_marker": [79, 85], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [325, 334], "entity_2_idx_in_text_with_entity_marker": [338, 347], "entity_2_idx_in_text_with_typed_entity_marker": [347, 356], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_115", "text": "We failed to provide evidence of an association between @GENE$ and NOS1AP rs7538490 and type 2 diabetes, overweight, @DISEASE$ or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_entity_marker": "We failed to provide evidence of an association between [E1]@GENE$[/E1] and NOS1AP rs7538490 and type 2 diabetes, overweight, [E2]@DISEASE$[/E2] or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_typed_entity_marker": "We failed to provide evidence of an association between [GENE]@GENE$[/GENE] and NOS1AP rs7538490 and type 2 diabetes, overweight, [DISEASE]@DISEASE$[/DISEASE] or related quantitative metabolic phenotypes in large-scale studies of Danes.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [56, 62], "entity_1_idx_in_text_with_entity_marker": [60, 66], "entity_1_idx_in_text_with_typed_entity_marker": [62, 68], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [117, 126], "entity_2_idx_in_text_with_entity_marker": [130, 139], "entity_2_idx_in_text_with_typed_entity_marker": [139, 148], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_213", "text": "Similarly, @GENE$ (AA) reduced the risk of cervical or @DISEASE$.", "text_with_entity_marker": "Similarly, [E1]@GENE$[/E1] (AA) reduced the risk of cervical or [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Similarly, [GENE]@GENE$[/GENE] (AA) reduced the risk of cervical or [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [11, 17], "entity_1_idx_in_text_with_entity_marker": [15, 21], "entity_1_idx_in_text_with_typed_entity_marker": [17, 23], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [55, 64], "entity_2_idx_in_text_with_entity_marker": [68, 77], "entity_2_idx_in_text_with_typed_entity_marker": [77, 86], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_134", "text": "These results suggest that combination of HDACi with adenoviral @GENE$ gene therapy may be a new therapeutic approach for the treatment of @DISEASE$ that warrants further investigation.", "text_with_entity_marker": "These results suggest that combination of HDACi with adenoviral [E1]@GENE$[/E1] gene therapy may be a new therapeutic approach for the treatment of [E2]@DISEASE$[/E2] that warrants further investigation.", "text_with_typed_entity_marker": "These results suggest that combination of HDACi with adenoviral [GENE]@GENE$[/GENE] gene therapy may be a new therapeutic approach for the treatment of [DISEASE]@DISEASE$[/DISEASE] that warrants further investigation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [64, 70], "entity_1_idx_in_text_with_entity_marker": [68, 74], "entity_1_idx_in_text_with_typed_entity_marker": [70, 76], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [139, 148], "entity_2_idx_in_text_with_entity_marker": [152, 161], "entity_2_idx_in_text_with_typed_entity_marker": [161, 170], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_191", "text": "Additionally, levels of @GENE$ were significantly lower in recalcitrant CRSwNP compared to controls and @DISEASE$.", "text_with_entity_marker": "Additionally, levels of [E1]@GENE$[/E1] were significantly lower in recalcitrant CRSwNP compared to controls and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Additionally, levels of [GENE]@GENE$[/GENE] were significantly lower in recalcitrant CRSwNP compared to controls and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [24, 30], "entity_1_idx_in_text_with_entity_marker": [28, 34], "entity_1_idx_in_text_with_typed_entity_marker": [30, 36], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [104, 113], "entity_2_idx_in_text_with_entity_marker": [117, 126], "entity_2_idx_in_text_with_typed_entity_marker": [126, 135], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_212", "text": "Especially, the SNP rs491347 and its strongly associated SNPs (e.g., @GENE$) could be important to human @DISEASE$ phenotypes.", "text_with_entity_marker": "Especially, the SNP rs491347 and its strongly associated SNPs (e.g., [E1]@GENE$[/E1]) could be important to human [E2]@DISEASE$[/E2] phenotypes.", "text_with_typed_entity_marker": "Especially, the SNP rs491347 and its strongly associated SNPs (e.g., [GENE]@GENE$[/GENE]) could be important to human [DISEASE]@DISEASE$[/DISEASE] phenotypes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [69, 75], "entity_1_idx_in_text_with_entity_marker": [73, 79], "entity_1_idx_in_text_with_typed_entity_marker": [75, 81], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [105, 114], "entity_2_idx_in_text_with_entity_marker": [118, 127], "entity_2_idx_in_text_with_typed_entity_marker": [127, 136], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_239", "text": "@GENE$ genotypes CG and variants carrying G allele showed statistical significance and very high risk of developing @DISEASE$ compared to wild type [CG vs CC; p<0.001, odds ratio (OR)=15.57, 95% confidence interval (CI)=6.56-36.98, CG+GG vs CC; p<0.001, OR=17.58, 95% CI=7.44-41.58].", "text_with_entity_marker": "[E1]@GENE$[/E1] genotypes CG and variants carrying G allele showed statistical significance and very high risk of developing [E2]@DISEASE$[/E2] compared to wild type [CG vs CC; p<0.001, odds ratio (OR)=15.57, 95% confidence interval (CI)=6.56-36.98, CG+GG vs CC; p<0.001, OR=17.58, 95% CI=7.44-41.58].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] genotypes CG and variants carrying G allele showed statistical significance and very high risk of developing [DISEASE]@DISEASE$[/DISEASE] compared to wild type [CG vs CC; p<0.001, odds ratio (OR)=15.57, 95% confidence interval (CI)=6.56-36.98, CG+GG vs CC; p<0.001, OR=17.58, 95% CI=7.44-41.58].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [116, 125], "entity_2_idx_in_text_with_entity_marker": [129, 138], "entity_2_idx_in_text_with_typed_entity_marker": [138, 147], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_197", "text": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of @DISEASE$ and intestinal cancer in GPx1 and @GENE$ double knockout mice.", "text_with_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of [E1]@DISEASE$[/E1] and intestinal cancer in GPx1 and [E2]@GENE$[/E2] double knockout mice.", "text_with_typed_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of [DISEASE]@DISEASE$[/DISEASE] and intestinal cancer in GPx1 and [GENE]@GENE$[/GENE] double knockout mice.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [94, 103], "entity_1_idx_in_text_with_entity_marker": [98, 107], "entity_1_idx_in_text_with_typed_entity_marker": [103, 112], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [138, 144], "entity_2_idx_in_text_with_entity_marker": [151, 157], "entity_2_idx_in_text_with_typed_entity_marker": [163, 169], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_1_66", "text": "These observations suggest that @GENE$ makes a substantial contribution to @DISEASE$ susceptibility, larger than that estimated from the population frequency of the R381Q variant.", "text_with_entity_marker": "These observations suggest that [E1]@GENE$[/E1] makes a substantial contribution to [E2]@DISEASE$[/E2] susceptibility, larger than that estimated from the population frequency of the R381Q variant.", "text_with_typed_entity_marker": "These observations suggest that [GENE]@GENE$[/GENE] makes a substantial contribution to [DISEASE]@DISEASE$[/DISEASE] susceptibility, larger than that estimated from the population frequency of the R381Q variant.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [32, 38], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_idx_in_text_with_typed_entity_marker": [38, 44], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [75, 84], "entity_2_idx_in_text_with_entity_marker": [88, 97], "entity_2_idx_in_text_with_typed_entity_marker": [97, 106], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_267", "text": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, @GENE$ and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.", "text_with_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, [E1]@GENE$[/E1] and rs3093662) were strikingly over-represented among forty-five Long Term [E2]@DISEASE$[/E2] controllers.", "text_with_typed_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, [GENE]@GENE$[/GENE] and rs3093662) were strikingly over-represented among forty-five Long Term [DISEASE]@DISEASE$[/DISEASE] controllers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [103, 109], "entity_1_idx_in_text_with_entity_marker": [107, 113], "entity_1_idx_in_text_with_typed_entity_marker": [109, 115], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_28", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, @GENE$, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, [E2]@GENE$[/E2], ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, [GENE]@GENE$[/GENE], ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [617, 623], "entity_2_idx_in_text_with_entity_marker": [630, 636], "entity_2_idx_in_text_with_typed_entity_marker": [642, 648], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_1_48", "text": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (@GENE$) locus and Crohn's disease (@DISEASE$) as a consequence of a genome-wide association study of this disease in adults.", "text_with_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor ([E1]@GENE$[/E1]) locus and Crohn's disease ([E2]@DISEASE$[/E2]) as a consequence of a genome-wide association study of this disease in adults.", "text_with_typed_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor ([GENE]@GENE$[/GENE]) locus and Crohn's disease ([DISEASE]@DISEASE$[/DISEASE]) as a consequence of a genome-wide association study of this disease in adults.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [132, 138], "entity_1_idx_in_text_with_entity_marker": [136, 142], "entity_1_idx_in_text_with_typed_entity_marker": [138, 144], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [167, 176], "entity_2_idx_in_text_with_entity_marker": [180, 189], "entity_2_idx_in_text_with_typed_entity_marker": [189, 198], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_107", "text": "Furthermore, we show that the HIV-DNA levels (reflecting the @DISEASE$ reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the @GENE$ gene).", "text_with_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [E1]@DISEASE$[/E1] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the [E2]@GENE$[/E2] gene).", "text_with_typed_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [DISEASE]@DISEASE$[/DISEASE] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the [GENE]@GENE$[/GENE] gene).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [61, 70], "entity_1_idx_in_text_with_entity_marker": [65, 74], "entity_1_idx_in_text_with_typed_entity_marker": [70, 79], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [281, 287], "entity_2_idx_in_text_with_entity_marker": [294, 300], "entity_2_idx_in_text_with_typed_entity_marker": [306, 312], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_1_292", "text": "Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of @GENE$ with the pathogenesis of @DISEASE$.", "text_with_entity_marker": "Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of [E1]@GENE$[/E1] with the pathogenesis of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of [GENE]@GENE$[/GENE] with the pathogenesis of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [183, 189], "entity_1_idx_in_text_with_entity_marker": [187, 193], "entity_1_idx_in_text_with_typed_entity_marker": [189, 195], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [215, 224], "entity_2_idx_in_text_with_entity_marker": [228, 237], "entity_2_idx_in_text_with_typed_entity_marker": [237, 246], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_174", "text": "Therefore, the mutations of the @GENE$ gene are thought to be related with the pathogenesis of @DISEASE$.", "text_with_entity_marker": "Therefore, the mutations of the [E1]@GENE$[/E1] gene are thought to be related with the pathogenesis of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Therefore, the mutations of the [GENE]@GENE$[/GENE] gene are thought to be related with the pathogenesis of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [32, 38], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_idx_in_text_with_typed_entity_marker": [38, 44], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [95, 104], "entity_2_idx_in_text_with_entity_marker": [108, 117], "entity_2_idx_in_text_with_typed_entity_marker": [117, 126], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_311", "text": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of @DISEASE$ and intestinal cancer in @GENE$ and GPx2 double knockout mice.", "text_with_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of [E1]@DISEASE$[/E1] and intestinal cancer in [E2]@GENE$[/E2] and GPx2 double knockout mice.", "text_with_typed_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of [DISEASE]@DISEASE$[/DISEASE] and intestinal cancer in [GENE]@GENE$[/GENE] and GPx2 double knockout mice.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [94, 103], "entity_1_idx_in_text_with_entity_marker": [98, 107], "entity_1_idx_in_text_with_typed_entity_marker": [103, 112], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [129, 135], "entity_2_idx_in_text_with_entity_marker": [142, 148], "entity_2_idx_in_text_with_typed_entity_marker": [154, 160], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_1_178", "text": "Vitamin D receptor (@GENE$) genotypes may influence @DISEASE$ risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.", "text_with_entity_marker": "Vitamin D receptor ([E1]@GENE$[/E1]) genotypes may influence [E2]@DISEASE$[/E2] risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.", "text_with_typed_entity_marker": "Vitamin D receptor ([GENE]@GENE$[/GENE]) genotypes may influence [DISEASE]@DISEASE$[/DISEASE] risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [20, 26], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_idx_in_text_with_typed_entity_marker": [26, 32], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [52, 61], "entity_2_idx_in_text_with_entity_marker": [65, 74], "entity_2_idx_in_text_with_typed_entity_marker": [74, 83], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_257", "text": "To assess clinical significance, 93 @DISEASE$ lesions were evaluated for expression of @GENE$ and VEGFR-1 by immunohistochemistry.", "text_with_entity_marker": "To assess clinical significance, 93 [E1]@DISEASE$[/E1] lesions were evaluated for expression of [E2]@GENE$[/E2] and VEGFR-1 by immunohistochemistry.", "text_with_typed_entity_marker": "To assess clinical significance, 93 [DISEASE]@DISEASE$[/DISEASE] lesions were evaluated for expression of [GENE]@GENE$[/GENE] and VEGFR-1 by immunohistochemistry.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [36, 45], "entity_1_idx_in_text_with_entity_marker": [40, 49], "entity_1_idx_in_text_with_typed_entity_marker": [45, 54], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [87, 93], "entity_2_idx_in_text_with_entity_marker": [100, 106], "entity_2_idx_in_text_with_typed_entity_marker": [112, 118], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_1_276", "text": "@GENE$ play crucial roles in DNA replication and @DISEASE$.", "text_with_entity_marker": "[E1]@GENE$[/E1] play crucial roles in DNA replication and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] play crucial roles in DNA replication and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [49, 58], "entity_2_idx_in_text_with_entity_marker": [62, 71], "entity_2_idx_in_text_with_typed_entity_marker": [71, 80], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_90", "text": "In case-control samples, two SNPs (@GENE$ and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for @DISEASE$ (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_entity_marker": "In case-control samples, two SNPs ([E1]@GENE$[/E1] and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for [E2]@DISEASE$[/E2] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_typed_entity_marker": "In case-control samples, two SNPs ([GENE]@GENE$[/GENE] and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for [DISEASE]@DISEASE$[/DISEASE] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [35, 41], "entity_1_idx_in_text_with_entity_marker": [39, 45], "entity_1_idx_in_text_with_typed_entity_marker": [41, 47], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [184, 193], "entity_2_idx_in_text_with_entity_marker": [197, 206], "entity_2_idx_in_text_with_typed_entity_marker": [206, 215], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_15", "text": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (@GENE$) locus and @DISEASE$ (CD) as a consequence of a genome-wide association study of this disease in adults.", "text_with_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor ([E1]@GENE$[/E1]) locus and [E2]@DISEASE$[/E2] (CD) as a consequence of a genome-wide association study of this disease in adults.", "text_with_typed_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor ([GENE]@GENE$[/GENE]) locus and [DISEASE]@DISEASE$[/DISEASE] (CD) as a consequence of a genome-wide association study of this disease in adults.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [132, 138], "entity_1_idx_in_text_with_entity_marker": [136, 142], "entity_1_idx_in_text_with_typed_entity_marker": [138, 144], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [150, 159], "entity_2_idx_in_text_with_entity_marker": [163, 172], "entity_2_idx_in_text_with_typed_entity_marker": [172, 181], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_20", "text": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of @GENE$, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected @DISEASE$ offspring were observed.", "text_with_entity_marker": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of [E1]@GENE$[/E1], significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected [E2]@DISEASE$[/E2] offspring were observed.", "text_with_typed_entity_marker": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of [GENE]@GENE$[/GENE], significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected [DISEASE]@DISEASE$[/DISEASE] offspring were observed.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [83, 89], "entity_1_idx_in_text_with_entity_marker": [87, 93], "entity_1_idx_in_text_with_typed_entity_marker": [89, 95], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [240, 249], "entity_2_idx_in_text_with_entity_marker": [253, 262], "entity_2_idx_in_text_with_typed_entity_marker": [262, 271], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_246", "text": "The present study suggests that genetic variation in or near the @GENE$ gene is associated with both psychotic and @DISEASE$, including schizophrenia and bipolar disorder.", "text_with_entity_marker": "The present study suggests that genetic variation in or near the [E1]@GENE$[/E1] gene is associated with both psychotic and [E2]@DISEASE$[/E2], including schizophrenia and bipolar disorder.", "text_with_typed_entity_marker": "The present study suggests that genetic variation in or near the [GENE]@GENE$[/GENE] gene is associated with both psychotic and [DISEASE]@DISEASE$[/DISEASE], including schizophrenia and bipolar disorder.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [65, 71], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_idx_in_text_with_typed_entity_marker": [71, 77], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [115, 124], "entity_2_idx_in_text_with_entity_marker": [128, 137], "entity_2_idx_in_text_with_typed_entity_marker": [137, 146], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_60", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, @GENE$ (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of @DISEASE$ (IBD), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, [E1]@GENE$[/E1] (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of [E2]@DISEASE$[/E2] (IBD), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, [GENE]@GENE$[/GENE] (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of [DISEASE]@DISEASE$[/DISEASE] (IBD), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [143, 149], "entity_1_idx_in_text_with_entity_marker": [147, 153], "entity_1_idx_in_text_with_typed_entity_marker": [149, 155], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [228, 237], "entity_2_idx_in_text_with_entity_marker": [241, 250], "entity_2_idx_in_text_with_typed_entity_marker": [250, 259], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_155", "text": "The HBS1L-MYB intergenic region on chromosome @GENE$ is a quantitative trait locus controlling fetal haemoglobin level in carriers of @DISEASE$.", "text_with_entity_marker": "The HBS1L-MYB intergenic region on chromosome [E1]@GENE$[/E1] is a quantitative trait locus controlling fetal haemoglobin level in carriers of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The HBS1L-MYB intergenic region on chromosome [GENE]@GENE$[/GENE] is a quantitative trait locus controlling fetal haemoglobin level in carriers of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [46, 52], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 58], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [134, 143], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_idx_in_text_with_typed_entity_marker": [156, 165], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_198", "text": "To clarify the involvement of gene variations in the promoter region of the gene encoding @GENE$ in this mRNA reduction, we analyzed DNA polymorphisms or mutations within this gene promoter region in @DISEASE$ patients by direct sequencing.", "text_with_entity_marker": "To clarify the involvement of gene variations in the promoter region of the gene encoding [E1]@GENE$[/E1] in this mRNA reduction, we analyzed DNA polymorphisms or mutations within this gene promoter region in [E2]@DISEASE$[/E2] patients by direct sequencing.", "text_with_typed_entity_marker": "To clarify the involvement of gene variations in the promoter region of the gene encoding [GENE]@GENE$[/GENE] in this mRNA reduction, we analyzed DNA polymorphisms or mutations within this gene promoter region in [DISEASE]@DISEASE$[/DISEASE] patients by direct sequencing.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [90, 96], "entity_1_idx_in_text_with_entity_marker": [94, 100], "entity_1_idx_in_text_with_typed_entity_marker": [96, 102], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [200, 209], "entity_2_idx_in_text_with_entity_marker": [213, 222], "entity_2_idx_in_text_with_typed_entity_marker": [222, 231], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_89", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, @GENE$ UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, [E2]@GENE$[/E2] UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, [GENE]@GENE$[/GENE] UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [428, 434], "entity_2_idx_in_text_with_entity_marker": [441, 447], "entity_2_idx_in_text_with_typed_entity_marker": [453, 459], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_1_314", "text": "An association with the minor allele A of the non-synonymous SNP @GENE$ (rs10735810, FokI, Met1Thr) was observed for @DISEASE$, with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02-1.57; p = 0.036).", "text_with_entity_marker": "An association with the minor allele A of the non-synonymous SNP [E1]@GENE$[/E1] (rs10735810, FokI, Met1Thr) was observed for [E2]@DISEASE$[/E2], with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02-1.57; p = 0.036).", "text_with_typed_entity_marker": "An association with the minor allele A of the non-synonymous SNP [GENE]@GENE$[/GENE] (rs10735810, FokI, Met1Thr) was observed for [DISEASE]@DISEASE$[/DISEASE], with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02-1.57; p = 0.036).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [65, 71], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_idx_in_text_with_typed_entity_marker": [71, 77], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [117, 126], "entity_2_idx_in_text_with_entity_marker": [130, 139], "entity_2_idx_in_text_with_typed_entity_marker": [139, 148], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_1_11", "text": "A total of 180 patients with @DISEASE$ were categorized as high IL-1RA producers if they were carriers of at least one of the @GENE$ or rs579543 T/T genotypes (T/T carriers).", "text_with_entity_marker": "A total of 180 patients with [E1]@DISEASE$[/E1] were categorized as high IL-1RA producers if they were carriers of at least one of the [E2]@GENE$[/E2] or rs579543 T/T genotypes (T/T carriers).", "text_with_typed_entity_marker": "A total of 180 patients with [DISEASE]@DISEASE$[/DISEASE] were categorized as high IL-1RA producers if they were carriers of at least one of the [GENE]@GENE$[/GENE] or rs579543 T/T genotypes (T/T carriers).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [29, 38], "entity_1_idx_in_text_with_entity_marker": [33, 42], "entity_1_idx_in_text_with_typed_entity_marker": [38, 47], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [126, 132], "entity_2_idx_in_text_with_entity_marker": [139, 145], "entity_2_idx_in_text_with_typed_entity_marker": [151, 157], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
